Last reviewed · How we verify
Angelicin (sitosterol)
Angelicin (generic name: sitosterol) is a sitosterol drug. It is currently FDA-approved.
Angelicin is a small molecule. It is a hydrophobic compound that is soluble in alcohols.
At a glance
| Generic name | sitosterol |
|---|---|
| Drug class | sitosterol |
| Target | DNA polymerase beta, Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy (PHASE1,PHASE2)
- MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (NA)
- Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycystic Ovary Syndrome (EARLY_PHASE1)
- Plant Sterol-Enriched Palm Oil to Improve Lipid Profile and Inflammation in Hyperlipidemic Individuals (NA)
- A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men. (NA)
- Fracture Pattern Following Bilateral Sagittal Split Osteotomy With or Without Impacted Third Molars (NA)
- Assessment of Therapeutic Potential of Stigma Maydis (Cornsilk) on Metabolic Syndrome (NA)
- Study of Dr. Pyke's Supplement for Stream (S4S) in Men With Prostatism and ED (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Angelicin CI brief — competitive landscape report
- Angelicin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Angelicin
What is Angelicin?
Angelicin (sitosterol) is a sitosterol drug.
What is the generic name of Angelicin?
sitosterol is the generic (nonproprietary) name of Angelicin.
What drug class is Angelicin in?
Angelicin belongs to the sitosterol class. See all sitosterol drugs at /class/sitosterol.
What development phase is Angelicin in?
Angelicin is FDA-approved (marketed).
What does Angelicin target?
Angelicin targets DNA polymerase beta, Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B and is a sitosterol.
Related
- Drug class: All sitosterol drugs
- Target: All drugs targeting DNA polymerase beta, Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing